Trial intelligence / Profile preview

Combining Glucagon and Insulin Infusion with Glucose Sensing in Subcutaneous Adipose Tissue of Type 1 Diabetes Patients

2015-002342-30Phase 4Completed

Sponsor
Medical University of Graz
Start
Jun 2015
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 4, single-arm trial of glucagon and insulin aspart in diabetes mellitus type 1 (T1D), sponsored by Medical University of Graz. Primary endpoint: Mean absolute relative difference (MARD). Started Jun 2015; status: completed.

02

Drugs

glucagoninsulin aspart
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2015-002342-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002342-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call